Latest Stories
Winners And Losers Of Q4: Biogen (NASDAQ:BIIB) Vs The Rest Of The Therapeutics Stocks
Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.
Q4 Earnings Outperformers: Credit Acceptance (NASDAQ:CACC) And The Rest Of The Consumer Finance Stocks
Looking back on consumer finance stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Credit Acceptance (NASDAQ:CACC) and its peers.
Reflecting On Diversified Financial Services Stocks’ Q4 Earnings: Paymentus (NYSE:PAY)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the diversified financial services stocks, including Paymentus (NYSE:PAY) and its peers.
Reinsurance Stocks Q4 In Review: Fidelis Insurance (NYSE:FIHL) Vs Peers
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Fidelis Insurance (NYSE:FIHL) and the rest of the reinsurance stocks fared in Q4.
Reflecting On Electronic Components Stocks’ Q4 Earnings: nLIGHT (NASDAQ:LASR)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how electronic components stocks fared in Q4, starting with nLIGHT (NASDAQ:LASR).
Reflecting On Regional Banks Stocks’ Q4 Earnings: Independent Bank (NASDAQ:INDB)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the regional banks industry, including Independent Bank (NASDAQ:INDB) and its peers.
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Charles River Laboratories (NYSE:CRL) and the rest of the drug development inputs & services stocks fared in Q4.
Unpacking Q4 Earnings: Trustmark (NASDAQ:TRMK) In The Context Of Other Regional Banks Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the regional banks industry, including Trustmark (NASDAQ:TRMK) and its peers.
Q4 Earnings Highs And Lows: Zurn Elkay (NYSE:ZWS) Vs The Rest Of The HVAC and Water Systems Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at hvac and water systems stocks, starting with Zurn Elkay (NYSE:ZWS).
Earnings To Watch: Sprinklr (CXM) Reports Q4 Results Tomorrow
Customer experience management platform Sprinklr (NYSE:CXM) will be reporting results this Wednesday before market open. Here’s what you need to know.